MK

Mayank Kulshrestha

Active Director Designated Partner DIN 08943231
DIN 08943231 First appointment May 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Mayank Kulshrestha

Data last updated:

Mayank Kulshrestha is a Designated Partner at Iconpharma Distributors Llp (since 2025). The company operates in Pharma.

DIN 08943231
Primary Designation Designated Partner
Industry Pharma
First Appointment 13 May 2025
Oldest Company Age 10 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner13 May 20252016Active

Board colleagues of Mayank Kulshrestha

NameDINCompanyDesignation
Mohit Kumar08235887Iconpharma Distributors LlpDesignated Partner
Reeti Kulshrestha07551343Iconpharma Distributors LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Iconpharma Distributors Llp
Premium access

Shareholding and investment profile for Mayank Kulshrestha

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mayank Kulshrestha

Mayank Kulshrestha currently holds 1 directorship: Iconpharma Distributors Llp (Designated Partner, since 13 May 2025).

Mayank Kulshrestha was first appointed on 13 May 2025 as Designated Partner at Iconpharma Distributors Llp.

The current boards of Mayank Kulshrestha's companies include Mohit Kumar (Iconpharma Distributors Llp), Reeti Kulshrestha (Iconpharma Distributors Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available